Treatment of osteoporosis in postmenopausal women and men at high risk of fracture; glucocorticoid-induced osteoporosis at high risk of fracture; increases bone mass and reduces fracture risk in severe osteoporosis as prescribed.
How It Works
Teriparatide is an anabolic (bone-building) agent. Intermittent administration stimulates osteoblast activity more than osteoclast activity, leading to new bone formation and increased bone mineral density, thereby lowering fracture risk.
Directions for Use
Use exactly as prescribed by a doctor. Usually given as a once-daily subcutaneous injection; do not inject into a vein or muscle. Take adequate calcium and vitamin D as advised. If dizziness occurs after injection, sit/lie down; learn correct injection technique and safe needle disposal.
Side Effects
Nausea, dizziness, headache, leg cramps, injection site pain/redness, fatigue, transient increase in blood calcium
Warnings & Precautions
Prescription-only medicine. Not recommended in patients with hypercalcemia, severe kidney impairment, bone metastases or skeletal malignancy, Paget’s disease of bone, unexplained elevated alkaline phosphatase, prior radiation therapy involving the skeleton, or in children/young adults with open epiphyses. Use with caution in kidney stones/urolithiasis; monitor calcium if advised. Limit total duration of therapy as per prescribing information; follow-up for bone health is required. Seek urgent care for signs of allergic reaction, severe dizziness/fainting, or symptoms of high calcium.
Manufacturer
MANKIND (PHARMA)
BrandMANKIND (PHARMA)
Drug Interactions
Digoxin (risk of arrhythmias with hypercalcemia), calcium/vitamin D supplements (may increase hypercalcemia risk), thiazide diuretics (may increase calcium), other medicines affecting calcium or bone metabolism (as directed by physician).
Storage Instructions
Store refrigerated at 2–8°C. Do not freeze. Protect from light. Keep the container/pen capped; do not use if frozen or if solution is cloudy/has particles. Keep out of reach of children.
Treatment of osteoporosis in postmenopausal women and men at high risk of fracture; glucocorticoid-induced osteoporosis at high risk of fracture; increases bone mass and reduces fracture risk in severe osteoporosis as prescribed.
What are the side effects?
Nausea, dizziness, headache, leg cramps, injection site pain/redness, fatigue, transient increase in blood calcium
How does this medicine work?
Teriparatide is an anabolic (bone-building) agent. Intermittent administration stimulates osteoblast activity more than osteoclast activity, leading to new bone formation and increased bone mineral density, thereby lowering fracture risk.
How should I use this medicine?
Use exactly as prescribed by a doctor. Usually given as a once-daily subcutaneous injection; do not inject into a vein or muscle. Take adequate calcium and vitamin D as advised. If dizziness occurs after injection, sit/lie down; learn correct injection technique and safe needle disposal.
How should I store this medicine?
Store refrigerated at 2–8°C. Do not freeze. Protect from light. Keep the container/pen capped; do not use if frozen or if solution is cloudy/has particles. Keep out of reach of children.
Do I need a prescription for this product?
Yes, this product requires a valid prescription (Rx). Upload it during checkout when prompted.
Can prices or availability change?
Yes. Prices and availability can change based on inventory and serviceability. The latest details are shown at checkout.
How do I place an order?
Select a variant, add to cart, enter delivery address, upload prescription if required, and pay securely.
Manufacturer & Brand
Brand:MANKIND (PHARMA)
Manufacturer:MANKIND (PHARMA)
HSN Code:30043919
Alternatives
Alternatives are suggested by pharmacists after reviewing your order and prescription.
Disclaimer: Product information is for awareness only and does not replace medical advice. For Rx medicines, a valid prescription is required. Consult your doctor or pharmacist for personalized guidance.
Sources: Manufacturer labeling/prescribing information, established medical literature on teriparatide, standard pharmacology references
